Inovio Stock: The Final Countdown To A Binary FDA Decision (NASDAQ:INO)
· seekingalpha.com
Inovio Pharmaceuticals is a single-asset, late-stage biotech, with value hinging on the October 30th PDUFA decision for INO-3107. Learn why INO stock is a hold.
I see Inovio Pharmaceuticals ( INO ) as effectively a single-asset, late-stage biotech in which the value is now almost entirely anchored to the regulatory outc...